KINETENSIN manufacturers
- Kinetensin
-
- $800.00
-
2025-04-08
- CAS:103131-69-7
- Min. Order: 1g
- Purity: 99 %
- Supply Ability: 500 Kg
- KINETENSIN
-
- $1.00
-
2020-03-06
- CAS:103131-69-7
- Min. Order: 1g
- Purity: ≥98%
|
| | KINETENSIN Basic information |
| | KINETENSIN Chemical Properties |
| storage temp. | 2-8°C | | solubility | TFA 0.1%: 1 mg/mL, clear, colorless | | form | Powder | | color | White to off-white | | Water Solubility | Soluble to 2 mg/ml in water | | Sequence | Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu |
| | KINETENSIN Usage And Synthesis |
| Uses | Kinetensin is a neurotensin-like peptide isolated from pepsin-treated human plasma. | | Definition | ChEBI: Kinetensin is an oligopeptide comprising of nine amino acids with sequence L-Ile-L-Ala-L-Arg-L-Arg-L-His-L-Pro-L-Tyr-L-Phe-L-Leu. It was originally isolated from pepsin-treated human plasma and shares some sequence homology with the C-terminal end of neurotensin. It is a potent histamine releaser and may serve as an inflammatory mediator. It has a role as a human metabolite and a histamine releasing agent. It is a conjugate base of a kinetensin(2+). | | in vivo | Kinetensin also induces a dose-dependent increase in vascular permeability when injected intradermally into rats[2]. | | IC 50 | Human Endogenous Metabolite | | References | [1] Mogard MH, et al. The amino acid sequence of kinetensin, a novel peptide isolated from pepsin-treated human plasma: homology with human serum albumin, neurotensin and angiotensin. Biochem Biophys Res Commun. 1986 May 14;136(3):983-8. DOI:10.1016/0006-291x(86)90429-8
[2] Sydbom A, et al. Stimulation of histamine release by the peptide kinetensin. Agents Actions. 1989 Apr;27(1-2):68-71. DOI:10.1007/BF02222201 |
| | KINETENSIN Preparation Products And Raw materials |
|